List of bibliographic references
Number of relevant bibliographic references: 87.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000006 (2020-03-24) |
Denis Efimov [France] ; Rosane Ushirobira [France] | On an interval prediction of COVID-19 development based on a SEIR epidemic model |
| 000033 (2020) |
Eduardo Lazcano-Ponce [Mexique] ; Celia Alpuche-Aranda [Mexique] | [Public health literacy in the face of the Covid-19 pandemic emergency]. |
| 000034 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
| 000044 (2020) |
Rong-Sheng Luan [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Xing-Shu Chen [République populaire de Chine] ; Tao Zhou [République populaire de Chine] ; Quan-Hui Liu [République populaire de Chine] ; Xin Lü [République populaire de Chine] ; Xian-Ping Wu [République populaire de Chine] ; Dong-Qing Gu [République populaire de Chine] ; Ming-Shuang Tang [République populaire de Chine] ; Hui-Jie Cui [République populaire de Chine] ; Xue-Feng Shan [République populaire de Chine] ; Jing Ouyang [République populaire de Chine] ; Ben Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Emergency Research Group Sichuan University Covid- [République populaire de Chine] | [Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review]. |
| 000050 (2020) |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
| 000051 (2020) |
Susannah Leach | [At least 68 vaccine candidates under development]. |
| 000060 (2020) |
Sergio Rosales-Mendoza [Mexique] | Will plant-made biopharmaceuticals play a role in the fight against COVID-19? |
| 000062 (2020) |
Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000067 (2020) |
Mary A. Lake [Royaume-Uni] | What we know so far: COVID-19 current clinical knowledge and research. |
| 000070 (2020) |
Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique] | What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? |
| 000078 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000087 (2020) |
Daniel B. Jernigan | Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. |
| 000103 (2020) |
Shan Lu | Timely development of vaccines against SARS-CoV-2 |
| 000115 (2020) |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000139 (2020) |
Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine] | The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. |
| 000165 (2020) |
Shibo Jiang [République populaire de Chine, États-Unis] ; Zheng-Li Shi [République populaire de Chine] | The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus |
| 000184 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000192 (2020) |
Jose Mose Balibrea [Espagne] ; Josep Mose Badia [Espagne] ; Inés Rubio Pérez [Espagne] ; Esteban Martín Antona [Espagne] ; Estíbaliz Álvarez Pe A [Espagne] ; Sandra García Botella [Espagne] ; Mario Álvarez Gallego [Espagne] ; Elena Martín Pérez [Espagne] ; Sagrario Martínez Cortijo [Espagne] ; Isabel Pascual Miguela Ez [Espagne] ; Lola Pérez Díaz [Espagne] ; Jose Luis Ramos Rodriguez [Espagne] ; Eloy Espin Basany [Espagne] ; Raquel Sánchez Santos [Espagne] ; Victoriano Soria Aledo [Espagne] ; Ruth L Pez Barrachina [Espagne] ; Salvador Morales-Conde [Espagne] | Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons. |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000201 (2020) |
Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde] | Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). |
| 000206 (2020) |
Qihui Wang [République populaire de Chine] ; Yanfang Zhang [République populaire de Chine] ; Lili Wu [République populaire de Chine] ; Sheng Niu [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Zengyuan Zhang [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Chengpeng Qiao [République populaire de Chine] ; Yu Hu [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Qisheng Wang [République populaire de Chine] ; Huan Zhou [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] | Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "development"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "development" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= development
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
